Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors
ConclusionsWaiting time longer than 6 months is associated to lower rates of tumor recurrence. Younger patients ≤ 45 years had significantly improved survival after LT for NET metastases.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Brain | Cancer & Oncology | Carcinoid Tumor | Gastroenterology | Liver | Liver Transplant | Neurology | Neurosurgery | Study | Surgery | Transplants | Urology & Nephrology